June 7, 2024

Insights and Updates on Navigating the AML Landscape

Insights and Updates on Navigating the AML Landscape
Insights and Updates on Navigating the AML Landscape
Treating Blood Cancers
Insights and Updates on Navigating the AML Landscape
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts TuneIn podcast player icon TuneIn TuneIn Spotify podcast player icon Spotify Spotify Amazon Music podcast player icon Amazon Music Amazon Music Deezer podcast player icon Deezer Deezer
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts TuneIn podcast player icon TuneIn TuneIn Spotify podcast player icon Spotify Spotify Amazon Music podcast player icon Amazon Music Amazon Music Deezer podcast player icon Deezer Deezer

Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX

Recorded on March 28, 2024


Hagop M. Kantarjian, MD
Hagop M. Kantarjian, M.D.
Professor and Chairman, Department of Leukemia
Samsung Distinguished University Chair in Cancer Medicine
MD Anderson Cancer Center, University of Texas
Houston, TX
Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!